Antiviral Medications for Herpes: Options and Side Effects

It's day two of a familiar tingling near the vulva, and the choice between calling in a prescription for a five-day antiviral course or asking about a daily pill has to be made within hours. That window matters more than you might think. Herpes antivirals only work well when you start them early, inside the first 24 to 48 hours after symptoms begin. Missing that window doesn't make them useless, but it does change what they can accomplish for you. This guide walks you through the three FDA-approved antivirals for genital herpes, how to choose between episodic and daily suppressive therapy, and what you actually need to tell your provider to make that decision.

Antiviral options for treating genital herpes

Three systemic antivirals are FDA-approved for genital herpes: acyclovir (Zovirax), valacyclovir (Valtrex), and famciclovir (Famvir). Valacyclovir is a prodrug of acyclovir with roughly 3 to 5 times higher bioavailability, which is why it can be dosed twice daily for outbreaks instead of acyclovir's five-times-daily schedule. Episodic treatment, typically 5 to 10 days, targets an active outbreak; daily suppressive therapy is a separate, ongoing strategy covered later in this post. None of the three drugs cures HSV or clears latent virus from nerve ganglia. They shorten and reduce the symptoms of active episodes, and similar treatment protocols exist for bacterial STIs like chlamydia and gonorrhea.

• Acyclovir (Zovirax): 400-800 mg five times daily for episodic treatment; longest clinical history, FDA Pregnancy Category B.
• Valacyclovir (Valtrex): 500 mg twice daily for episodic treatment; higher bioavailability allows less-frequent dosing and better absorption.
• Famciclovir (Famvir): 250 mg three times daily for episodic treatment; similar efficacy to valacyclovir but less commonly used due to higher cost.

According to CDC guidance on STI treatment, all three are considered first-line agents. Your provider will choose among them based on dosing frequency, cost, kidney function, and whether you're pregnant or breastfeeding.

How herpes antivirals work in the body

All three antivirals are nucleoside analogs. Viral thymidine kinase converts them into their active triphosphate form inside infected cells. The active drug then blocks viral DNA polymerase, stopping the virus from copying its genetic material while largely sparing uninfected cells. Starting treatment within 24 to 48 hours of the first tingle, itch, or visible lesion is the window that determines how much the drug shortens an outbreak. Because the drug only acts during active viral replication, it cannot reach or eliminate HSV while it is dormant inside nerve cells. This is why antivirals are not a cure and why recurrences happen after treatment stops.

What is the safest antiviral for herpes?

Acyclovir has the longest track record, in continuous clinical use since 1982, with an extensive pregnancy and long-term safety database. All three drugs are FDA Pregnancy Category B and are considered compatible with current breastfeeding guidance. Kidney function is the main variable that changes the safety calculus: dose adjustment is needed for reduced renal function with any of the three drugs. Decision rule: dosing frequency and cost more often distinguish the options than safety, since adverse-event rates are similar across all three.

"Systemic antiviral drugs partially control the signs and symptoms of herpes episodes when used to treat first clinical episodes, recurrent episodes, or as daily suppressive therapy."

— CDC STI Treatment Guidelines

What are valacyclovir's side effects?

Most common: headache and nausea, each reported in roughly 10 to 15% of users in clinical trials. Less common side effects include abdominal pain, dizziness, and vomiting. A rare but serious concern is thrombotic thrombocytopenic purpura and hemolytic uremic syndrome (TTP/HUS), which has occurred almost exclusively at the very high doses used in advanced HIV or transplant care, not standard herpes dosing. Confusion and agitation are more likely in people with reduced kidney function, since the drug is cleared renally. Mayo Clinic notes that headache and nausea are the most commonly reported valacyclovir side effects, while high-dose use has been linked to rare kidney and blood-clotting effects.

• Common: Headache, nausea, abdominal pain.
• Less common: Dizziness, vomiting.
• Rare: TTP/HUS (only at very high doses, not standard herpes treatment); confusion or agitation in people with kidney impairment.
• Drug interactions: Probenecid and cimetidine can increase valacyclovir levels; inform your provider of all medications.

Daily suppressive therapy: when antivirals become an everyday medication

Suppressive therapy is typically considered at 6 or more outbreaks per year, or for any couple where one partner wants to lower transmission risk. Standard suppressive dosing is valacyclovir 500 mg once daily; famciclovir 250 mg twice daily and acyclovir 400 mg twice daily are the alternative regimens. Daily suppressive valacyclovir is also used late in pregnancy, generally starting around 36 weeks, to reduce viral shedding before delivery. This decision to move from episodic to suppressive therapy is a conversation with your provider, not a one-time prescription. Suppressive therapy is revisited with a provider annually to assess whether the frequency of outbreaks has changed or whether you want to continue. Understanding how suppressive therapy factors into vaginal delivery decisions is important if pregnancy is something you're planning.

The CDC reports that daily suppressive valacyclovir reduces the risk of transmitting genital herpes to a susceptible partner, with trial data showing roughly a 48% reduction in transmission risk. This doesn't mean zero risk, but it's a meaningful shift in the odds for couples deciding on safer sex practices together.

Is there a downside to taking antivirals?

Antivirals do not eradicate latent virus or change the frequency or severity of future recurrences once the medication is stopped. Daily suppressive therapy still allows for asymptomatic viral shedding and does not reduce transmission risk to zero. Cost and adherence are practical downsides: generic valacyclovir costs less than brand Valtrex, but years of daily dosing is a real adherence burden for some people. Antiviral resistance is rare in people with normal immune function but is a documented concern in immunocompromised patients on long-term therapy.

"These medications do not eradicate latent virus and do not affect the risk, frequency, or severity of recurrences after the drug is discontinued."

— CDC Sexual Health Guidelines

Beyond the medical side effects, there are questions around disclosure and how to navigate confidentiality protections that apply to ongoing herpes treatment. Your provider should respect your privacy and work with you on these conversations.

How herpes antivirals differ from other medications you might already take

Ozempic and Mounjaro are GLP-1 receptor agonists for diabetes and weight management; their signature nausea and GI side effects share no mechanism with antiviral therapy. Gabapentin is sometimes prescribed off-label for nerve pain associated with an outbreak, not to fight the virus itself, and its main side effects are drowsiness and dizziness. Prednisone is an immunosuppressive steroid generally avoided during an active herpes flare, since suppressing the immune system can worsen an outbreak. Flu antivirals like oseltamivir and oral antifungals like fluconazole for thrush target influenza virus and Candida fungus, entirely different pathogens and drug classes than HSV antivirals. Lexapro, an SSRI for mood, is unrelated to any of them.

• Ozempic / Mounjaro: GLP-1 agonists for diabetes and weight; GI side effects unrelated to antivirals.
• Gabapentin: Off-label nerve pain relief; does not fight HSV, causes drowsiness.
• Prednisone: Immunosuppressive steroid; generally avoided during active herpes flares.
• Flu antivirals (oseltamivir): Target influenza virus only; entirely different drug class.
• Thrush antifungals (fluconazole): Target Candida fungus; not antivirals, not used for herpes.
• Lexapro: SSRI for mood; no overlap with antiviral therapy.

How can you heal herpes sores faster?

Starting antiviral treatment within 24 to 48 hours of first symptoms remains the single biggest factor in how fast a sore heals. Pro tip: keep the area clean and dry, wear loose cotton underwear, and avoid tight clothing to reduce friction that delays healing. Over-the-counter pain relief (acetaminophen or ibuprofen) and cool compresses manage discomfort but do not speed viral clearance the way antivirals do.

• Start antivirals within 24 to 48 hours of first tingle, itch, or visible lesion.
• Keep sores clean and dry; wash gently with soap and water, then pat dry.
• Wear loose cotton underwear and avoid tight pants or friction on the area.
• Use acetaminophen or ibuprofen for pain, and apply cool compresses (10 to 15 minutes at a time) for comfort.
• Avoid sexual contact until all lesions are fully crusted over and healed.
• Do not pick at scabs or attempt to pop lesions; let them heal without interference.

Action: contact a provider within the first day or two of new or worsening symptoms so antiviral treatment starts inside its effective window. Waiting more than 48 hours makes the medication less able to cut short your outbreak, even though it can still reduce pain and secondary bacterial infection.

Talk with a provider before you start suppressive therapy

A provider visit within 24 to 48 hours of new symptoms is the actionable step that determines whether antiviral treatment works as intended. Bring an accurate outbreak count per year to that visit; it's the number that determines episodic versus daily suppressive therapy. If you have a partner, ask directly about suppressive therapy's transmission-risk reduction as part of shared decision-making. The choice between episodic and suppressive therapy isn't one-size-fits-all. Some people have rare outbreaks and prefer episodic treatment. Others have frequent recurrences or want to reduce transmission risk and find daily therapy worth the cost and adherence burden. Your provider can walk you through the realistic timeline for healing (typically 7 to 10 days for an outbreak, shorter with early antiviral start) and help you track whether your pattern changes over time. When you're ready to dive deeper into sexual health information backed by research, explore more evidence-based sexual health guides on this site.